Stocks and Investing
Stocks and Investing
Mon, January 4, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, December 31, 2020
[ 12:00 AM ] - WOPRAI
Wed, December 30, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, December 29, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, December 28, 2020
[ 12:00 AM ] - WOPRAI
Michelle Gilson Maintained (STOK) at Strong Buy with Increased Target to $72 on, Dec 28th, 2020
Michelle Gilson of Canaccord Genuity, Maintained "Stoke Therapeutics, Inc." (STOK) at Strong Buy with Increased Target from $53 to $72 on, Dec 28th, 2020.
Michelle has made no other calls on STOK in the last 4 months.
There are 3 other peers that have a rating on STOK. Out of the 3 peers that are also analyzing STOK, 0 agree with Michelle's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Michelle
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $56 on, Friday, December 11th, 2020
- Martin Auster of "Credit Suisse" Maintained at Buy with Increased Target to $49 on, Friday, November 13th, 2020
- Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $49 on, Friday, October 23rd, 2020
Contributing Sources